The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Weight loss jabs, known as GLP-1 receptor agonists, work by reducing food cravings. In October, the MHRA told health ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

NEW YORK, Jan. 22 (UPI) --As demand for weight-loss injections sold under brand names ... Advertisement With the drugs' novelty and soaring popularity, it's important for consumers to know about ...

The new drug, amycretin, similar to the company's blockbuster weight-loss and diabetes drugs Wegovy ... The company tested the once-weekly injection on 125 people for up to 36 weeks with ...

There are precedents for a hybrid NHS-private model of healthcare. Ten years ago, a new drug treatment arrived that could ...

It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are ...